Chronic Disease Flexible Coverage Act

119th Congress Introduced by Vern Buchanan and 2 co-sponsors

HR 919 improves healthcare for chronic disease patients by offering flexible insurance options, reducing costs, and ensuring access to preventive services and education.

Received in the Senate and Read twice and referred to the Committee on Finance.

Purpose and Intent

The Chronic Disease Flexible Coverage Act (HR 919) aims to enhance healthcare coverage for individuals suffering from chronic diseases. The bill seeks to provide more flexible options for insurance coverage, ensuring that patients have access to necessary treatments and services without facing prohibitive costs or restrictions.

Key Provisions

Flexible Coverage Options: The bill proposes to allow insurance providers to offer more tailored coverage plans specifically designed for individuals with chronic conditions. This includes the ability to customize benefits based on the unique needs of patients.

Cost Sharing Adjustments: HR 919 aims to reduce out-of-pocket expenses for patients with chronic diseases by adjusting cost-sharing requirements. This may involve lower copayments for essential medications and treatments.

Preventive Services: The legislation emphasizes the importance of preventive care by requiring insurance plans to cover certain preventive services without cost-sharing. This is intended to encourage early intervention and management of chronic conditions.

Patient Education and Support: The bill includes provisions for funding programs that provide education and support to patients managing chronic diseases, helping them navigate their treatment options and healthcare systems.

Affected Parties

Patients with Chronic Diseases: Individuals suffering from conditions such as diabetes, heart disease, and asthma will benefit from improved coverage options and reduced financial burdens.

Healthcare Providers: Medical professionals and institutions may see changes in how they bill for services related to chronic disease management, potentially leading to increased patient engagement and better health outcomes.

Insurance Companies: Insurers will need to adapt their plans to comply with the new flexible coverage requirements, which may involve restructuring existing policies.

Legislative Timeline

Introduced: February 4, 2025

House Actions:

February 4, 2025: Referred to the House Committee on Ways and Means.
March 4, 2025: Passed in the House after a motion to suspend the rules and pass the bill was agreed to by voice vote.
March 4, 2025: Debate occurred for forty minutes prior to the vote.

Senate Actions:

March 5, 2025: Received in the Senate, read twice, and referred to the Committee on Finance for further consideration.

Conclusion

HR 919 represents a significant step towards improving healthcare accessibility for individuals with chronic diseases. By promoting flexible coverage options and reducing financial barriers, the bill aims to enhance the quality of care and support for affected patients. The ongoing legislative process will determine the final shape and implementation of these provisions.

Bill